Research presented at the European Congress on Obesity in 2024, for instance, found that people who gradually reduced their dose to zero (over an average of nine weeks) maintained a stable body weight in the first 26 weeks after tapering
In Phase 3 TRIUMPH-1 data, dysesthesia occurred in 5.1%, 12.3%, and 12.5% of participants taking retatrutide 4 mg, 9 mg, and 12 mg, compared with 0.9% of participants receiving placebo
Common Side Effects in the First Week While most users tolerate Semaglutide well, some may experience: Mild nausea (usually subsides within a few days) Constipation or diarrhoea Fatigue or slight dizziness Mild headaches These side effects are typically temporary
These combination products have their own metabolic effects that stack on top of berberine when both are used
Often, there might be symptoms such as fever, fatigue, malaise, or headaches even before the rash appears